Standard

Neurofibromatosis, type 1

NF1 · rs768777585

Stands on its own. Nothing else here links to this position yet — but the page above is the point: what the research found, what each genotype means, and where it came from, in language you can read. Links to conditions, drugs and the senses appear automatically if we write them.

Strength of the evidence

There is no record yet to score this position by (a ClinVar disease classification or a genome-wide significant study). That is not the same as weak evidence.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10⁻⁵⁰. 2: ClinVar from one lab (1 star), or p ≤ 10⁻²⁰. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10⁻⁸). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What ClinVar records

Classification Conflicting classifications of pathogenicity for Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome and 1 more; criteria provided, conflicting classifications (1 of 4 stars, 11 submitters), last evaluated 2026-05-14. ClinVar record 185589 NM_001042492.3(NF1):c.354C>T (p.Cys118=)

Classification Pathogenic for Neurofibromatosis, type 1; criteria provided, single submitter (1 of 4 stars, 1 submitter), last evaluated 2021-01-09. ClinVar record 1361844 NM_001042492.3(NF1):c.354C>A (p.Cys118Ter)

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-09 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

CT

World gnomAD

C 100.0%

World TOPMed

C 100.0%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. No Korean figure for this position yet.

What each result means

A/A Two copies of the version ClinVar lists as disease-causing for Neurofibromatosis, type 1. A result like this should be confirmed by a medical genetic test and talked through with a doctor; consumer DNA files can misread rare variants. So far only one lab has made this call, so it may change. (ClinVar VCV001361844, criteria provided, single submitter)

A/C One copy of the version ClinVar lists as disease-causing for Neurofibromatosis, type 1. Some conditions need only one copy; for others, one copy makes a person a carrier who is usually healthy but can pass it on. A genetic counsellor can say which applies. So far only one lab has made this call, so it may change. (ClinVar VCV001361844, criteria provided, single submitter)

C/C No copy of the version ClinVar lists as disease-causing for Neurofibromatosis, type 1. This is the usual result. So far only one lab has made this call, so it may change. (ClinVar VCV001361844, criteria provided, single submitter)

Source: ClinVar VCV001361844, criteria provided, single submitter

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Neurofibromatosis, type 1 (rs768777585). MyGeneLog™. https://www.mygenelog.com/variants/rs768777585

← See all variants